Two-year-old Evans was brought to the Nyumbani Children’s Home in Nairobi, Kenya a year ago, suffering from HIV and ...

The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...

South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded ...

Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...

The decline in D.C. HIV cases is a positive trend, but funding cuts could impact future prevention work. Derrick “Strawberry” ...

The median (IQR) age of the people living with HIV (PLWH) was 49 (38-57) years, with the recently-arrived GBM having a median ...

Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...

One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...

A new HIV drug, lenacapavir, appears highly effective against strains circulating in Uganda, according to a study led by ...

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...

The U.N.'s Angeli Achrekar reports that many clinics have closed, despite exemptions in the policy. She fears mortality will ...

A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.